Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Encompass Health discloses FY2025 compensation for 5 named executive officers, totaling $6.0M. Mark J. Tarr, the Executive Officer, accounts for 43% of that combined total.
Mark J. Tarr's total compensation rose 21% year-over-year, from $2.1M in FY2024 to $2.6M in FY2025.
Cash compensation (salary plus bonus) made up 58% of Encompass Health's FY2025 tracked executive pay, with stock awards accounting for 170%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Encompass Health's combined tracked executive pay of $6.0M ranks in the 28th percentile (industry median: $13.6M). Its highest-paid executive, Mark J. Tarr, ranks in the 23th percentile for top-executive pay in the sector (industry median: $6.3M).
Compensation figures on this page for Encompass Health come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.